Seamless phase II/III clinical trials using early outcomes for treatment or subgroup selection: Methods and aspects of their implementation

01/24/2019
by   Tim Friede, et al.
0

Adaptive seamless designs combine confirmatory testing, a domain of phase III trials, with features such as treatment or subgroup selection, typically associated with phase II trials. They promise to increase the efficiency of development programmes of new drugs, e.g. in terms of sample size and / or development time. It is well acknowledged that adaptive designs are more involved from a logistical perspective and require more upfront planning, often in form of extensive simulation studies, than conventional approaches. Here we present a framework for adaptive treatment and subgroup selection using the same notation, which links the somewhat disparate literature on treatment selection on one side and on subgroup selection on the other. Furthermore, we introduce a flexible and yet efficient simulation model that serves both designs. As primary endpoints often take a long time to observe, interim analyses are frequently informed by early outcomes. Therefore, all methods presented accommodate both, interim analyses informed by the primary outcome or an early outcome. The R package asd, previously developed to simulate designs with treatment selection, was extended to include subpopulation selection (so-called adaptive enrichment designs). Here we describe the functionality of the R package asd and use it to present some worked-up examples motivated by clinical trials in chronic obstructive pulmonary disease and oncology. The examples illustrate various features of the R package providing at the same time insights into the operating characteristics of adaptive seamless studies.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
04/07/2021

Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspective

Clinical trials are an instrument for making informed decisions based on...
research
06/23/2020

Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs

Adaptive designs for clinical trials permit alterations to a study in re...
research
11/27/2020

Design aspects of COVID-19 treatment trials: Improving probability and time of favourable events

As a reaction to the pandemic of the severe acute respiratory syndrome c...
research
05/28/2020

Clinical trials impacted by the COVID-19 pandemic: Adaptive designs to the rescue?

Very recently the new pathogen severe acute respiratory syndrome coronav...
research
12/18/2020

Multi-outcome trials with a generalised number of efficacious outcomes

Existing multi-outcome designs focus almost entirely on evaluating wheth...
research
08/05/2021

Improving the Power of Economic Experiments Using Adaptive Designs

An important issue for many economic experiments is how the experimenter...
research
08/08/2022

Sensitivity Analyses of Clinical Trial Designs: Selecting Scenarios and Summarizing Operating Characteristics

The use of simulation-based sensitivity analyses is fundamental to evalu...

Please sign up or login with your details

Forgot password? Click here to reset